51
Views
22
CrossRef citations to date
0
Altmetric
Original Article

The Role of the Angiopoietins in Tumour Angiogenesis

, &
Pages 1-11 | Received 17 Jun 2003, Published online: 07 Aug 2009

References

  • Acker, T., Beck, H. and Plate, K.H. (2001) "Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularisation", Mechanisms Dev. 108, 45-57.
  • Anderson, A.R.A. and Chaplain, M.A.J. (1998) "Continuous and discrete mathematical models of tumour-induced angiogenesis", Bull. Math. Biol. 60, 857-900.
  • Arakelyan, L., Vainstein, V. and Agur, Z. (2003a) "A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumour growth", Angiogenesis 5.
  • Arakelyan, L., Merbl, Y., Daugulis, P., Ginosar, Y., Vainstein, V., Selitser, V., Kogan, Y., Harpak, H. and Agur, Z. (2003b) "Multi-scale analysis of angiogenic dynamics and therapy", In: Preziosi, L., ed, Cancer modelling and simulation, (CRC Press, London), pp. 185-220.
  • Ashara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G.D. and Isner, J.M. (1998) "Tie-2 receptor ligands, angiopoietin 1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularisation", Circ. Res. 83, 233-240.
  • Ausprunk, D.H. and Folkman, J. (1977) "Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis", Microvasc. Res. 14, 53-65.
  • Balding, D. and McElwain, D.L.S. (1985) "Mathematical modelling of tumour-induced capillary growth", J. Theor. Biol. 114, 53-73.
  • Beck, H., Acker, T., Wiessner, C., Allegrini, P.R. and Plate, K.H. (2000) "Expression of angiopoietin-1, angiopoietin-2 and Tie receptors after middle cerebral artery occlusion in the rat", Am. J. Path. 157, 1473-1483.
  • Byrne, H.M. and Chaplain, M.A.J. (1995) "Mathematical models for tumour angiogenesis: numerical simulations and nonlinear wave solutions", Bull. Math. Biol. 57, 461-486.
  • Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Van den Hoeck, A., Harpal, K., Eberhardt, C., De Clercq, C., Pawling, J. and Moons, L. (1996) "Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele", Nature 380, 435-439.
  • Chaplain, M.A.J., Giles, S.M., Sleeman, B.D. and Jarvis, R.J. (1995) "A mathematical model for tumour angiogenesis", J. Math. Biol. 33, 744-770.
  • Currie, M.J., Gunningham, S.P., Turner, K., Han, C., Scott, P.A.E., Robinson, B.A., Chong, W., Harris, A.L. and Fox, S.B. (2002) "Expression of the angiopoietins and their receptor Tie-2 in human renal clear cell carcinomas; regulation by the von Hippel-Landau gene and hypoxia", J. Path. 198, 502-510.
  • Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C. and Yancopoulos, G.D. (1996) "Isolation of angiopoietin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning", Cell 87, 1161-1169.
  • Folkman, J. (1971) "Tumour angiogenesis: therapeutic implications", N. Engl. J. Med. 285, 1182-1186.
  • Gale, N.W., Thurston, G., Hackett, S.F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M.H., Jackson, D., Suri, C., Campochiaro, P.A., Wiegand, S.J. and Yancopoulos, G.D. (2002) "Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning and only the latter role is rescued by angiopoietin-l", Dev. Cell 3, 411-423.
  • Hackett, S.F., Ozaki, H., Strauss, R.W., Wahlin, K., Suri, C., Maisonpierre, P., Yancopoulos, G. and Campochiaro, P.A. (2000) "Angiopoietin-2 expression in the retina: upregulation during physiologic and pathologic neovascularisation", J. Cell Physiol. 184, 275-284.
  • Han, Z.C. and Liu, Y. (1999) "Angiogenesis: state of the art", Int. J. Haematol. 70, 68-82.
  • Harfouche, R., Hassessian, H.M., Guo, Y., Faivre, V., Srikant, C.B., Yancopoulos, G.D. and Hussain, S.N.A. (2002) "Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells", Microvasc. Res. 64, 135-147.
  • Jones, P.F. (1997) "Tied up (or down?) with angiopoietins", Angiogenesis 1, 38-44.
  • Joussen, A.M., Poulaki, V., Tsujikawa, A., Qin, W., Qaum, T., Xu, Q., Moromizato, Y., Bursell, S., Wiegand, S.J., Rudge, J., Ioffe, E., Yancopoulos, G.D. and Adamis, A.P. (2002) "Suppression of diabetic retinopathy with angiopoietin-1", Am. J. Path. 160, 1683-1693.
  • Klagsbrun, M. and D'Amore, P.A. (1996) "Vascular endothelial growth factor and its receptors", Cytokine Growth Fact. Rev. 7, 259-270.
  • Levine, H.A., Sleeman, B.D. and Nilsen-Hamilton, M. (2000) "A mathematical model of the roles of pericytes and macrophages in the initiation of angiogenesis: I. the role of protease inhibitors in preventing angiogenesis", Math. Biosci. 168, 77-115.
  • Levine, H.A., Pamuk, S., Sleeman, B.D. and Nilsen-Hamilton, M. (2001) "A mathematical model of capillary formation and development in tumour angiogenesis: penetration into the stroma", Bull. Math. Biol. 63, 801-863.
  • Lobov, I.B., Brooks, P.C. and Lang, R.A. (2002) "Angiopoietin-2 displays vascular endothelial growth factor-dependent modulation of capillary structure and endothelial cell survival in vivo", Proc. Natl Acad. Sci. USA 99, 11205-11210.
  • Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papandopoulos, N., Daly, T.J., Davis, S. and Sato, T.N. (1997) "Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis", Science 277, 55-60.
  • Oh, H., Takagi, H., Suzuma, K., Otani, A., Matsumura, M. and Honda, Y. (1999) "Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells", J. Biol. Chem. 274, 15732-15739.
  • Othmer, H.G. and Stevens, A. (1997) "Aggregation, blowup and collapse: the ABC's of taxis and reinforced random walks", SIAM J. Appl. Math. 57, 1044-1081.
  • Papetti, M. and Herman, I.M. (2002) "Mechanisms of normal and tumour-derived angiogenesis", Am. J. Physiol. Cell Physiol. 282, C947-C970.
  • Paweletz, N. and Kneirim, M. (1989) "Tumour related angiogenesis", Crit. Rev. Oncol. Haematol. 9, 197-242.
  • Plank, M.J. and Sleeman, B.D. (2003) "A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies", IMA J. Math. Med. Biol. 20, 135-181.
  • Plank, M.J., Sleeman, B.D. and Jones, P.F. (2003) "A mathematical model of tumour angiogenesis regulated by vascular endothelial growth factor and the angiopoietins", J. Theor. Biol., submitted.
  • Sleeman, B.D. and Wallis, I.P. (2002) "Tumour induced angiogenesis as a reinforced random walk: modelling capillary network formation without endothelial cell proliferation", J. Math. Comp. Model. 36, 339-358.
  • Stokes, C.L. and Lauffenburger, D.A. (1991) "Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis", J. Theor. Biol. 152, 377-403.
  • Sundberg, C., Kowanetz, M., Brown, L.F., Detmar, M. and Dvorak, H.F. (2002) "Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo", Lab. Invest. 82, 387-401.
  • Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1996) "Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis", Cell 87, 1171-1180.
  • Thurston, G., Rudge, J.S., Ioffe, E., Zhou, H., Ross, L., Croll, S.D., Glazer, N., Holash, J., McDonald, D.M. and Yancopoulos, G.D. (2000) "Angiopoietin-1 protects the adult vasculature against plasma leakage", Nat. Med. 6, 460-463.
  • Uemura, A., Ogawa, M., Hirashima, M., Fujiwara, T., Koyama, S., Takagi, H., Honda, Y., Wiegand, S.J., Yancopoulos, G.D. and Nishikawa, S.I. (2002) "Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells", J. Clin. Invest. 110, 1619-1628.
  • Unemori, E.N., Ferrara, N., Bauer, E.A. and Amento, E.P. (1992) "Vascular endothelial growth factor induces interstital collagenase expression in human endothelial cells", J. Cell Physiol. 153, 557-562.
  • Vajkoczy, P., Farhadi, M., Gaumann, A., Heidenreich, R., Erber, R., Wunder, A., Tonn, J.C., Menger, M.D. and Breier, G. (2002) "Microtumour growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2 and angiopoietin-2", J. Clin. Invest. 109, 777-785.
  • Witzenbichler, B., Maisonpierre, P.C., Jones, P., Yancopoulos, G.D. and Isner, J.M. (1998) "Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie-2", J. Biol. Chem. 273, 18514-18521.
  • Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J. and Holash, J. (2000) "Vascular-specific growth factors and blood vessel formation", Nature 407, 242-249.
  • Zagzag, D., Hooper, A., Friedlander, D.R., Chan, W., Holash, J., Wiegand, S.J., Yancopoulos, G.D. and Grumet, M. (1999) "In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumour angiogenesis", Exp. Neurol. 159, 391-400.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.